Home » Topics » Regulatory

Regulatory
RSS

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Oncaspar approved in Canada

Dec. 5, 1997

Gensia Laboratories receives generic approval

Dec. 5, 1997

Intermittent therapy with 5-HT reuptake inhibitor effective for dysphoric PMS

Dec. 3, 1997

Imitrex Nasal Spray now available in U.S.

Dec. 2, 1997

Muse approved in U.K.

Dec. 2, 1997

Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS

Dec. 2, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

Teva receives FDA approval for generic etodolac

Dec. 1, 1997

European approvals for RPR's Nasacort AQ

Nov. 28, 1997